http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20030040350-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4035 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-06 |
| filingDate | 2001-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20030040350-A |
| titleOfInvention | Thiophene retinoids |
| abstract | The present invention relates to novel RAR selective retinoid agonists of formula (I) and pharmaceutically active salts of carboxylic acids of formula (I), and to said retinoic acid receptor agonists, in particular retinoic acid receptor γ, for example for treating emphysema and related lung diseases. RARγ) relates to the use of selective agents:n n n Formula In n n n n n n n Wheren n n R is hydrogen, alkyl, alkoxy, benzyl or phenethyl;n n n R 1 is hydrogen or alkyl;n n n X is C (R 2 R 3 ) and m is an integer of 1, 2 or 3, or X is oxygen, sulfur or NH and m is 1;n n n R 2 and R 3 are independently of each other hydrogen or lower alkyl. |
| priorityDate | 2000-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 128.